Form 4: Apyx Medical Corp Director Baylor-Henry Granted Stock Options

Director Minnie Baylor-Henry of Apyx Medical Corp was granted stock options on May 15, 2025.

Summary

• Minnie Baylor-Henry, a director of Apyx Medical Corp, was granted stock options to purchase 59,000 shares of common stock on May 15, 2025.
• The exercise price of the options is $1.48 per share.
• The options vest ratably over a 12-month period and become fully vested and exercisable on the first anniversary of the grant date.
• The options expire on May 15, 2035.

Sentiment

Score: 6

Explanation: The document simply reports a stock option grant, which is a neutral event. It suggests alignment of interests but doesn't inherently indicate positive or negative performance.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Stock option grants are a typical component of compensation packages for directors in publicly traded companies, particularly in growth-oriented sectors like medical technology.
• The vesting schedule of 12 months is fairly standard.
• The exercise price is set at $1.48.

Stakeholder Impact

• The stock option grant could incentivize the director to work towards increasing shareholder value.
• The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock options, director, Apyx Medical Corp, beneficial ownership, Form 4, Baylor-Henry, equity